These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26051991)

  • 1. Animal models of glucocorticoid-induced glaucoma.
    Overby DR; Clark AF
    Exp Eye Res; 2015 Dec; 141():15-22. PubMed ID: 26051991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis.
    Patel PD; Kodati B; Clark AF
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
    Patel GC; Millar JC; Clark AF
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.
    Jain A; Wordinger RJ; Yorio T; Clark AF
    J Ocul Pharmacol Ther; 2014; 30(2-3):121-7. PubMed ID: 24506296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic sciences in clinical glaucoma: steroids, ocular hypertension, and glaucoma.
    Clark AF
    J Glaucoma; 1995 Oct; 4(5):354-69. PubMed ID: 19920699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intraocular pressure in mice treated with dexamethasone.
    Whitlock NA; McKnight B; Corcoran KN; Rodriguez LA; Rice DS
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6496-503. PubMed ID: 20671272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Steroid treatment and risk of glaucoma].
    Jeppesen P; Krag S
    Ugeskr Laeger; 2015 Aug; 177(34):1620-3. PubMed ID: 26561657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular response analyser to assess hysteresis and corneal resistance factor in low tension, open angle glaucoma and ocular hypertension.
    Shah S; Laiquzzaman M; Mantry S; Cunliffe I
    Clin Exp Ophthalmol; 2008 Aug; 36(6):508-13. PubMed ID: 18954311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of steroids in outflow resistance.
    Clark AF; Wordinger RJ
    Exp Eye Res; 2009 Apr; 88(4):752-9. PubMed ID: 18977348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steroid treatment and risk of glaucoma].
    Jeppesen P; Krag S
    Ugeskr Laeger; 2014 Aug; 176(35):. PubMed ID: 25293703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid therapy and ocular hypertension.
    Dibas A; Yorio T
    Eur J Pharmacol; 2016 Sep; 787():57-71. PubMed ID: 27388141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management.
    Roberti G; Oddone F; Agnifili L; Katsanos A; Michelessi M; Mastropasqua L; Quaranta L; Riva I; Tanga L; Manni G
    Surv Ophthalmol; 2020; 65(4):458-472. PubMed ID: 32057761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Steroid induced ocular hypertension and glaucoma].
    Călugăru D; Călugăru M
    Oftalmologia; 2009; 53(3):15-33. PubMed ID: 19899544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids.
    Garbe E; LeLorier J; Boivin JF; Suissa S
    Lancet; 1997 Oct; 350(9083):979-82. PubMed ID: 9329512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescein filling defects of the optic nerve head in normal tension glaucoma, primary open-angle glaucoma, ocular hypertension and healthy controls.
    Plange N; Kaup M; Huber K; Remky A; Arend O
    Ophthalmic Physiol Opt; 2006 Jan; 26(1):26-32. PubMed ID: 16390479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-cone, L + M-cone, and pattern, electroretinograms in ocular hypertension and glaucoma.
    Aldebasi YH; Drasdo N; Morgan JE; North RV
    Vision Res; 2004 Nov; 44(24):2749-56. PubMed ID: 15342219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.
    Fingert JH; Clark AF; Craig JE; Alward WL; Snibson GR; McLaughlin M; Tuttle L; Mackey DA; Sheffield VC; Stone EM
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):145-52. PubMed ID: 11133859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
    Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
    Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma phenotype in pedigrees with the myocilin Thr377Met mutation.
    Mackey DA; Healey DL; Fingert JH; Coote MA; Wong TL; Wilkinson CH; McCartney PJ; Rait JL; de Graaf AP; Stone EM; Craig JE
    Arch Ophthalmol; 2003 Aug; 121(8):1172-80. PubMed ID: 12912696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
    Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
    Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.